Biologic Production Facility Considerations

Scott Koepsell, MD, PhD
Professor, Department of Pathology, Microbiology and Immunology, UNMC

Module Information

This module is part of Delivering Discovery: Cell Therapy Administration in the Clinical Research Setting (Enduring Material Modules)

Upon completion of this enduring material module, the participant should be better able to:

Summarize the role and workflow of the Biologic Production Facility with cellular therapy products.
Describe why the chain of identity and custody are important to the Biologic Production Facility.

Physicians
The University of Nebraska Medical Center designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
0.75 Nursing Contact Hours Awarded
Nebraska Medicine is approved as a provider of nursing continuing professional development by VTL Center for Professional Development, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. VTL Center for PD Provider Approval Number: NE1028-6

Read the UNMC CCE Disclosure Declaration Policy

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.

FACULTY

The following has disclosed relevant financial relationships:

Scott Koepsell, MD, PhD

CONSULTANT: Wefen

PLANNING COMMITTEE

The following has disclosed relevant financial relationships:

Matthew A. Lunning, DO, FACP
CONSULTANT: AbbVie Inc.; Acrotech Biopharma Inc.; Astellas Pharma Inc.; AstraZeneca; Fate Therapeutics; Genentech, Inc.; Genmab A/S; Miltenyi Biotec; Morphosys US Inc.; Nurix Therapeutics, Inc.; Pharmacyclics LLC
HONORARIUM RECIPIENT: AbbVie Inc.; Acrotech Biopharma; Astellas; AstraZeneca; Fate Therapeutics; Genentech; Genmab; Miltenyi Biotec; Morphosys; Nurix; Pharmacyclics
CONSULTANT (Terminated): ADC Therapeutics SA; EUSA Pharma; InstilBio; Novartis Pharmaceuticals Corporation
HONORARIUM RECIPIENT (Terminated): ADC Therapeutics; EUSA; InstilBio; Novartis Pharmaceuticals
GRANT/RESEARCH SUPPORT (Terminated): Bristol-Meyers Squibb Company; Curis, Inc.

The following have nothing to disclose:

Amy Fitzgerald, BSN, RN
Serena Gaines, MBA, MSN, RN, CPN
Tori Greenlee
Julie Huglin
Jacqueline Siebels, BSN, RN, NPD-BC
Sarah Snook, BSN, RN

Before You Begin (Important Instructions)

This activity takes approximately 45 minutes to complete. Please ensure you have enough time to finish the entire activity in one sitting. Do not close your browser or leave midway, as this may result in loss of progress and require you to restart.

Accessing the Activity & Receiving Credit

Click Begin On-Demand Activity to open the registration page in a new tab.
Complete your registration.
Click View Content on the confirmation screen to launch the webinar.
Important: Keep the registration tab open. It is required to track your progress and unlock credit.
To receive credit, you must:
- View the content in its entirety
- Complete the post-test
- Submit the evaluation
After completion, your certificate will be available in your UNMC MyCCE account under Certificates & Transcripts.

Begin On-Demand Activity Opens external link in new tab.